The recent changes in many state laws around the use of cannabis and cannabis- containing products has markedly changed the landscape around drug testing. False positives—and even false negatives—can lead to a lack of confidence in the entire drug testing process. In this presentation, there we will discuss the impact of cannabidiol-containing products (CBD) on the interpretation of both presumptive and definitive testing. Particular emphasis will be applied to test interpretation of positive results in the context of “allowable or prescribed” confounding drugs.
Learning Objectives:
Discuss drug testing methods in the context of state vs federal law
Examine the Hemp Farming Act 2018, especially as it applies to CBD
Explain how the “false positive drug test” can happen
List what your patient can do about the “false positive drug test”
Review your options in the context of marijuana use and prescription opioids
.jpg "Doug L. Gourlay, MD, MSc, FRCPC, FASAM photo")